About Us
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Press Centre
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Portfolio
Products by trade name
Back
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
BOSAURIN, tablets, 2 mg
International nonproprietary name : diazepam
Product category : Prescription medicines (Rx)
Strength : 2 mg
Pharmaceutical form : tablets
Packaging : 30 tablets
Pharmacotherapeutic group :
N
NERVOUS SYSTEM
N05
PSYCHOLEPTICS
N05B
ANXIOLYTICS
N05BA
Benzodiazepine derivatives
N05BA01
Diazepam
BOSAURIN, tablets, 5 mg
International nonproprietary name : diazepam
Product category : Prescription medicines (Rx)
Strength : 5 mg
Pharmaceutical form : tablets
Packaging : 30 tablets
Pharmacotherapeutic group :
N
NERVOUS SYSTEM
N05
PSYCHOLEPTICS
N05B
ANXIOLYTICS
N05BA
Benzodiazepine derivatives
N05BA01
Diazepam
BOSAURIN, tablets, 10 mg
International nonproprietary name : diazepam
Product category : Prescription medicines (Rx)
Strength : 10 mg
Pharmaceutical form : tablets
Packaging : 30 tablets
Pharmacotherapeutic group :
N
NERVOUS SYSTEM
N05
PSYCHOLEPTICS
N05B
ANXIOLYTICS
N05BA
Benzodiazepine derivatives
N05BA01
Diazepam
Q&A
If you have a question about any of our products, check whether it has already been answered in the Questions and Answers section.
TAKE A LOOK AT Q&A
If you are unable to find the answer under Q&A, then send your question and one of our medical or pharmaceutical experts will answer.
Newsletter
If you are a medical doctor or pharmacist, why not subscribe to our mailing list and receive the latest updates.
